There is increasing interest from many types of research groups in biocatalysis, in the application of enzymes which can replace chemical catalysts in synthetic processes, in the pharmaceutical and fine chemical industries.
Lipases are one of the most commonly used classes of enzymes in biocatalysis, while proteases have a broad range of opportunities in process design.
Novozymes offers a range of enzymes for biocatalysis and have an agreement between them and distributors Strem Inc which enables interested pharmaceutical manufacturers, universities, biotechs, and researchers to test Novozymes’ enzymes in their production processes or laboratories.
Novozymes’ Enzyme Screening Kits, available in the UK and Ireland, offer a fast, efficient way of easily accessing Novozymes’ portfolio of enzymes. Containing proven enzymes and lipase and protease enzymes used in the biocatalysis process that not only enable new, more sustainable routes for the production of intermediates and APIs, but offer commercial benefits such as better and more sustainable production, fewer side reactions and purification steps – all of which add up to lower costs, for the pharmaceutical and fine chemical specialist industries.